Piers Gaunt

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 15, 2026
Addition of zoledronic acid to consolidation chemotherapy in Ewing sarcoma-EURO EWING 2012 (EE2012): an international, open-label, randomised controlled phase III trial.

Brennan Bernadette, Laura Kirton, Perrine Marec-Bérard

|Feb 27, 2026
Promoting engagement in patient-initiated follow-up and self-care behaviours: acceptability of the 'ACT now & check-it-out' intervention for head and neck cancer (PETNECK2 study).

Lauren Matheson, Eila Watson, Tessa Fulton-Lieuw

|Jan 14, 2025
Development and internal validation of prognostic models for event-free survival in newly diagnosed Ewing sarcoma patients based on routinely collected clinical characteristics from the European randomised controlled trial, EE2012.

Laura Kirton, Richard Riley, Piers Gaunt

|Feb 08, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plans.

Victoria Homer, Christina Yap, Simon Bond

Pageof 1

Frequent Collaborators

1 joint publications

Laura Kirton

1 joint publications

Richard Riley

1 joint publications

Kym Snell

1 joint publications

Lauren Matheson